Deal Dispatch: QXO Nabs TopBuild For $17 Million, Voya Financial Urged To Evaluate Strategic Options, Pat McGrath Exits Chapter 11

FierceBiotechGSK’s $700M Alector bet blows up as Alzheimer’s drug flunks phase 2

FierceBiotechAvalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs

FierceBiotechAstraZeneca plucks preclinical EGFR degrader from Pinetree for $25M

Novo NordiskIs Novo Nordisk's GLP-1 dominance fading after Lilly's clinical wins? - MSN

Siemens HealthineersSiemens Healthineers: A €6 Billion Diagnostics Exit and a Coming Spin-Off as Shares Hit Rock Botto - AD HOC NEWS

BioPharma DiveAvalyn, in pursuit of better lung drugs, banks $300M in an IPO

Sinopharm Chemical Reagent Co., Ltd.Stabilizers Price in China - Market Insights - IndexBox

Insilico MedicineInsilico Medicine Secures IND Clearance For Rentosertib Inhalation Solution To Advance Targeted IPF Therapy - BioPharma APAC

MedtronicMedtronic Advances First Clinical Cases with Stealth AXiS™ Surgical System, Demonstrating the Power of Connected Smart Ecosystems Across Neurosurgery - Orthopedics This Week

Boston ScientificBoston Scientific Corporation (BSX): Stephen Mandel Opens New Position in Medical Device Firm - Yahoo Finance

10x Genomics NewsVanguard holds 6.17M shares of 10X Genomics (NASDAQ: TXG), 5.24% stake - Stock Titan

10x Genomics Blog10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan